Researchers in infectious disease, epidemiology, vaccines, and global health

Melvin Spigelman

Melvin Spigelman is a physician and tuberculosis drug-development researcher who serves as President and CEO of the TB Alliance, which developed pretomanid, approved by the FDA in 2019.

Mercedes Pascual

Mercedes Pascual is a Uruguayan theoretical ecologist at New York University who models infectious diseases, known for linking cholera to El Niño and winning the 2014 MacArthur Award.

Merle A. Sande (1939–2007) was an American infectious-diseases physician-researcher who led San Francisco General Hospital's early AIDS response, co-developed universal precautions, and built HIV treatment capacity in Uganda.

Mervyn Susser

Mervyn Susser (1921–2014) was a South African-born epidemiologist at Columbia University known for linking disease to social conditions and for Dutch Hunger Winter famine studies.

Meta Roestenberg

Meta Roestenberg is a Dutch infectious-diseases physician and professor of vaccinology at Leiden University Medical Center, known for controlled human infection models for malaria and vaccine testing.

Michael Boeckh

Michael Boeckh is a German-trained physician-scientist in Seattle who leads viral infection research at Fred Hutch and the University of Washington, focusing on cytomegalovirus in transplant recipients.

Michael F. Good

Michael F. Good is an Australian immunologist known for malaria and Strep A vaccine research whose candidate vaccines have entered clinical trials, and Director of QIMR from 2000.

Michael H. Alderman

Michael H. Alderman, born 1936, is an American physician and epidemiologist at Albert Einstein College of Medicine, known for hypertension research and for challenging public health campaigns to lower dietary salt.

Michael H. Merson

Michael H. Merson is an American physician and epidemiologist known for directing WHO's diarrheal disease control and global AIDS programs and founding the Duke Global Health Institute in 2006.

Michael Houghton

Michael Houghton (born 1949) is a British virologist who led the discovery of the hepatitis C virus and shared the 2020 Nobel Prize in Physiology or Medicine.

Michael K. Mansour

Michael K. Mansour is an infectious-diseases physician-scientist at Massachusetts General Hospital and Harvard Medical School, known for research on how the immune system recognizes fungal pathogens and for a 2020 tocilizumab Covid-19 trial.

Michael Klompas

Michael Klompas is a Canadian-trained infectious disease physician and hospital epidemiologist at Brigham and Women's Hospital and Harvard whose EHR-based sepsis surveillance shaped CDC definitions.

Michael Lanzer

Michael Lanzer (born 1959 in Düsseldorf) is a German parasitologist who studies the malaria parasite Plasmodium falciparum, heading Parasitology at Heidelberg University Hospital since 1999.

Michael Levin (medical researcher)

Michael Levin is a pediatric infectious diseases consultant and Chair in Paediatrics and International Child Health at Imperial College London, known for research on meningococcal disease and childhood tuberculosis.

Michael Marmot

Sir Michael Marmot, born 1945, is a British epidemiologist at University College London known for the Whitehall studies, the social gradient, and the 2010 Marmot Review.

Michael Osterholm

Michael Osterholm, American infectious disease epidemiologist, Regents Professor and director of CIDRAP at the University of Minnesota; former Minnesota state epidemiologist (1984–1999), Biden COVID-19 transition adviser, and author of Deadliest Enemy and The Big One.

Michael S. Glickman

Michael S. Glickman is an American infectious-disease physician and mycobacteriologist at Memorial Sloan Kettering Cancer Center in New York, known for research on how tuberculosis bacteria survive immune attack and antibiotics.

Michael S. Saag

Michael S. Saag is an American infectious-diseases physician and HIV researcher at the University of Alabama at Birmingham, where he founded the 1917 HIV Clinic and led early antiretroviral trials.

Michael Worobey

Michael Worobey is a Canadian evolutionary biologist at the University of Arizona who uses viral genomes to pinpoint how HIV, the 1918 influenza, and SARS-CoV-2 emerged and spread.

Michael Zasloff

Michael A. Zasloff is an American immunologist and biotechnology entrepreneur known for discovering magainin peptides in frog skin and squalamine, and is a professor at Georgetown University.

Michail S. Lionakis

Michail S. Lionakis is a Greek-born American infectious diseases physician-scientist who is Chief of the Laboratory of Clinical Immunology and Microbiology at NIAID, studying immunity to fungi such as Candida and Aspergillus.

Michele Heisler

Michele Heisler is an American physician-investigator at the University of Michigan and VA Ann Arbor, elected to the National Academy of Medicine in 2022 for research on health, human rights, and health equity.

Michelle Bell

Michelle Bell is an environmental health scientist at Yale who studies how air pollution, weather, and climate affect health, elected to the National Academy of Medicine in 2020.

Mickey Chopra

Mickey Chopra is a physician and global-health specialist who leads service delivery in the World Bank's health practice, previously Chief of Health at UNICEF and a South African Medical Research Council researcher.

Miguel A. Hernán

Miguel A. Hernán is a physician-epidemiologist and biostatistician, Kolokotrones Professor at the Harvard T.H. Chan School of Public Health, known for target trial emulation and the textbook Causal Inference: What If.

Miguel Ángel Martínez‐González

Miguel Ángel Martínez-González, born 1957, is a Spanish physician and epidemiologist at the University of Navarra and Harvard, known for the PREDIMED Mediterranean diet trial.

Mika Kivimäki

Mika Kivimäki is a Finnish epidemiologist who is Professor and Chair of Social Epidemiology at University College London, known for meta-analyses of work stress, long working hours, and heart disease.

Miriam J. Alter

Miriam J. Alter is an American epidemiologist who led the CDC's sentinel-county hepatitis surveillance, showed hepatitis C usually becomes chronic, and later worked at the University of Texas Medical Branch.